Video

ecancer's extensive video archive features interviews, panel discussions and conference coverage on almost every topic in oncology.

Real-world increase in biomarker testing in lung cancer

Dr Virginia Calvo de Juan - Hospital Universitario Puerta de Hierro-Majadahonda, Madrid, Spain
Real-world increase in biomarker testing in lung cancer ( Dr Virginia Calvo de Juan - Hospital Universitario Puerta de Hierro-Majadahonda, Madrid, Spain )
30 Mar 2022

EGFR testing: Best practice for NSCLC patients with exon 20 insertions

Dr Antonio Passaro, Dr Umberto Malapelle and Dr Joshua Sabari
EGFR testing: Best practice for NSCLC patients with exon 20 insertions ( Dr Antonio Passaro, Dr Umberto Malapelle and Dr Joshua Sabari )
30 Mar 2022

Minimal residual disease in multiple myeloma

Prof Ola Landgren - University of Miami, Miami, USA
Minimal residual disease in multiple myeloma ( Prof Ola Landgren - University of Miami, Miami, USA )
8 Mar 2022

Real-world evidence on PET use in Hodgkin lymphoma: An Argentinian perspective

Dr Marta Zerga - Hospital Alemán , Buenos Aires, Argentina
Real-world evidence on PET use in Hodgkin lymphoma: An Argentinian perspective ( Dr Marta Zerga - Hospital Alemán , Buenos Aires, Argentina )
3 Mar 2022

An AI-derived digital pathology-based biomarker to predict the benefit of ADT in PC with validation in NRG/RTOG 9408

Prof Daniel Spratt - University Hospitals Seidman Cancer Center, Cleveland, USA
An AI-derived digital pathology-based biomarker to predict the benefit of ADT in PC with validation in NRG/RTOG 9408 ( Prof Daniel Spratt - University Hospitals Seidman Cancer Center, Cleveland, USA )
3 Mar 2022

Survival outcomes of unilateral RB based on pathological risk stratification-experience at a tertiary care centre in Pakistan

Dr Palwasha Rehman - Shaukat Khanum Memorial Cancer Hospital and Research Centre, Lahore, Pakistan
Survival outcomes of unilateral RB based on pathological risk stratification-experience at a tertiary care centre in Pakistan ( Dr Palwasha Rehman - Shaukat Khanum Memorial Cancer Hospital and Research Centre, Lahore, Pakistan )
1 Mar 2022

Cancer nursing in India: Febrile neutropenia

Dr Krishnamani Kalpathi - American Oncology Institute, Hyderabad, India
Cancer nursing in India: Febrile neutropenia ( Dr Krishnamani Kalpathi - American Oncology Institute, Hyderabad, India )
28 Feb 2022

Cancer nursing in India: Tumour lysis syndrome

Dr Krishnamani Kalpathi - American Oncology Institute, Hyderabad, India
Cancer nursing in India: Tumour lysis syndrome ( Dr Krishnamani Kalpathi - American Oncology Institute, Hyderabad, India )
28 Feb 2022

SG in combination with pembro in patients with mUC who progressed after platinum (PLT)-based regimens

Dr Petros Grivas - Seattle Cancer Care Alliance, Seattle, USA
SG in combination with pembro in patients with mUC who progressed after platinum (PLT)-based regimens ( Dr Petros Grivas - Seattle Cancer Care Alliance, Seattle, USA )
28 Feb 2022

NMIBC treated with IL-15RαFc superagonist N-803 and BCG infusion

Prof Sam Chang - Vanderbilt University School of Medicine, Nashville, USA
NMIBC treated with IL-15RαFc superagonist N-803 and BCG infusion ( Prof Sam Chang - Vanderbilt University School of Medicine, Nashville, USA )
28 Feb 2022

Evaluating a polygenic hazard score to predict risk of developing metastatic or fatal prostate cancer

Dr Meghana Pagadala - University of California San Diego, San Diego, USA
Evaluating a polygenic hazard score to predict risk of developing metastatic or fatal prostate cancer ( Dr Meghana Pagadala - University of California San Diego, San Diego, USA )
25 Feb 2022

Atezolizumab with or without radiotherapy for advanced squamous cell carcinoma of the penis

Dr Hielke Martijn de Vries - Netherlands Cancer Institute, Amsterdam, The Netherlands
Atezolizumab with or without radiotherapy for advanced squamous cell carcinoma of the penis ( Dr Hielke Martijn de Vries - Netherlands Cancer Institute, Amsterdam, The Netherlands )
24 Feb 2022